Hackers are exploiting a maximum-severity vulnerability, tracked as CVE-2025-59528, in the open-source platform Flowise for ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Let’s pretend there’s a giant switch we could flip that would shut down all the injection wells in Southeast Ohio. Environmental activists will, of course, jump for joy. Susan Vessels might even calm ...

Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 ...

Claude extension flaw enabled silent prompt injection via XSS and weak allowlist, risking data theft and impersonation until ...

Over the past two years, there has been a heated debate about the closure of overdose prevention sites, not just in Alberta cities such as Red Deer, but also in Toronto and Ottawa. Such supervised ...

Here's what the next 24 hours should look like for Artemis II. Commander Reid Wiseman, Victor Glover, Christina Koch and ...

Within days of each other, Anthropic first leaked the source code to Claude Code, and then a critical vulnerability was found ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

CVE-2025-59528 exploited in Flowise for over six months across 12,000+ exposed instances, enabling full system compromise.